Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-01-19-Speech-3-383-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-01-19"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20110119.20.3-383-000"2
lpv:hasSubsequent	lp_eu:2011-01-19-Speech-3-383-5002
lpv:speaker	lp:Andreas Mölzer2
lpv:spokenAs	substitute; AFCO (2009-07-16--2012-01-18)3 member; NA (2009-07-14--2014-06-30)3 member; AFET (2009-07-16--2012-01-18)3 member; Delegation to the EU-Ukraine Parliamentary Cooperation Committee (2009-09-16--2014-06-30)3 unknown; Freiheitliche Partei Österreichs (2009-07-14--2014-06-30)3 substitute; Delegation to the EU-Chile Joint Parliamentary Committee (2009-09-16--2014-06-30)3
lpv:translated text	"Council Directive 93/42/EEC concerning medical devices explains precisely which requirements a device must meet, firstly in order to be authorised, and secondly, in order to remain on the market. If a product has a CE mark, then it fulfils these requirements. It is the responsibility of the Member States to put controls in place to prevent the unauthorised use of the CE mark and, if necessary, to have products withdrawn from the market. The relevant authority must inform the Commission immediately of any measures of this kind that have been taken. I have abstained from voting, because in my opinion, there is no need for the Commission to act in this case."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph